{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:57Z","timestamp":1790610837590,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T00:00:00Z","timestamp":1288915200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/2.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Fam Pract"],"published-print":{"date-parts":[[2010,12]]},"DOI":"10.1186\/1471-2296-11-85","type":"journal-article","created":{"date-parts":[[2010,11,5]],"date-time":"2010-11-05T15:15:45Z","timestamp":1288970145000},"source":"Crossref","is-referenced-by-count":70,"title":["Evaluation of the safety and efficacy of pregabalin in older patients with neuropathic pain: results from a pooled analysis of 11 clinical studies"],"prefix":"10.1186","volume":"11","author":[{"given":"David","family":"Semel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T Kevin","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gergana","family":"Zlateva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birol","family":"Emir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,11,5]]},"reference":[{"key":"507_CR1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2147\/CIA.S1681","volume":"3","author":"C Haslam","year":"2008","unstructured":"Haslam C, Nurmikko T: Pharmacological treatment of neuropathic pain in older persons. Clin Interv Aging. 2008, 3: 111-120.","journal-title":"Clin Interv Aging"},{"key":"507_CR2","doi-asserted-by":"publisher","first-page":"695","DOI":"10.1517\/14740338.6.6.695","volume":"6","author":"JA Salazar","year":"2007","unstructured":"Salazar JA, Poon I, Nair M: Clinical consequences of polypharmacy in elderly: expect the unexpected, think the unthinkable. Expert Opin Drug Saf. 2007, 6: 695-704. 10.1517\/14740338.6.6.695.","journal-title":"Expert Opin Drug Saf"},{"key":"507_CR3","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.critrevonc.2003.04.004","volume":"48","author":"JC Delafuente","year":"2003","unstructured":"Delafuente JC: Understanding and preventing drug interactions in elderly patients. Crit Rev Oncol Hematol. 2003, 48: 133-143. 10.1016\/j.critrevonc.2003.04.004.","journal-title":"Crit Rev Oncol Hematol"},{"key":"507_CR4","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1080\/03602530902722679","volume":"41","author":"U Klotz","year":"2009","unstructured":"Klotz U: Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009, 41: 67-76. 10.1080\/03602530902722679.","journal-title":"Drug Metab Rev"},{"key":"507_CR5","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.amjopharm.2004.09.005","volume":"2","author":"G Oster","year":"2004","unstructured":"Oster G, Berger A, Dukes E, Edelsberg J, McCarberg B: Use of potentially inappropriate pain-related medications in older adults with painful neuropathic disorders. Am J Geriatr Pharmacother. 2004, 2: 163-170. 10.1016\/j.amjopharm.2004.09.005.","journal-title":"Am J Geriatr Pharmacother"},{"key":"507_CR6","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1155\/2007\/713835","volume":"12","author":"J Lachaine","year":"2007","unstructured":"Lachaine J, Gordon A, Choini\u00e8re M, Collet JP, Dion D, Tarride JE: Painful neuropathic disorders: an analysis of the R\u00e9gie de l'Assurance Maladie du Qu\u00e9bec database. Pain Res Manag. 2007, 12: 31-37.","journal-title":"Pain Res Manag"},{"key":"507_CR7","doi-asserted-by":"publisher","first-page":"1153","DOI":"10.1111\/j.1468-1331.2006.01511.x","volume":"13","author":"N Attal","year":"2006","unstructured":"Attal N, Cruccu G, Haanpaa M, Hansson P, Jensen TS, Nurmikko T, Sampaio C, Sindrup S, Wiffen P, EFNS Task Force: EFNS guidelines on pharmacological treatment of neuropathic pain. Eur J Neurol. 2006, 13: 1153-1169. 10.1111\/j.1468-1331.2006.01511.x.","journal-title":"Eur J Neurol"},{"key":"507_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1007\/s11916-006-0043-x","volume":"10","author":"BR Stacey","year":"2006","unstructured":"Stacey BR, Swift JN: Pregabalin for neuropathic pain based on recent clinical trials. Curr Pain Headache Rep. 2006, 10: 179-184. 10.1007\/s11916-006-0043-x.","journal-title":"Curr Pain Headache Rep"},{"key":"507_CR9","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1212\/01.WNL.0000055433.55136.55","volume":"60","author":"RH Dworkin","year":"2003","unstructured":"Dworkin RH, Corbin AE, Young JP, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology. 2003, 60: 1274-1283.","journal-title":"Neurology"},{"key":"507_CR10","doi-asserted-by":"publisher","first-page":"2104","DOI":"10.1212\/01.WNL.0000145767.36287.A1","volume":"63","author":"H Lesser","year":"2004","unstructured":"Lesser H, Sharma U, LaMoreaux L, Poole RM: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial. Neurology. 2004, 63: 2104-2110.","journal-title":"Neurology"},{"key":"507_CR11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jpain.2004.12.007","volume":"6","author":"RW Richter","year":"2005","unstructured":"Richter RW, Portenoy R, Sharma U, LaMoreaux L, Bockbrader H, Knapp LE: Relief of painful diabetic peripheral neuropathy with pregabalin: a randomized, placebo-controlled trial. J Pain. 2005, 6: 253-260. 10.1016\/j.jpain.2004.12.007.","journal-title":"J Pain"},{"key":"507_CR12","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.pain.2004.05.001","volume":"110","author":"J Rosenstock","year":"2004","unstructured":"Rosenstock J, Tuchman M, LaMoreaux L, Sharma U: Pregabalin for the treatment of painful diabetic peripheral neuropathy: a double-blind, placebo-controlled trial. Pain. 2004, 110: 628-638. 10.1016\/j.pain.2004.05.001.","journal-title":"Pain"},{"key":"507_CR13","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.pain.2004.01.001","volume":"109","author":"R Sabatowski","year":"2004","unstructured":"Sabatowski R, Galvez R, Cherry DA, Jacquot F, Vincent E, Maisonobe P, Versavel M, 1008-045 Study Group: Pregabalin reduces pain and improves sleep and mood disturbances in patients with post-herpetic neuralgia: results of a randomised, placebo-controlled clinical trial. Pain. 2004, 109: 26-35. 10.1016\/j.pain.2004.01.001.","journal-title":"Pain"},{"key":"507_CR14","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.pain.2005.02.032","volume":"115","author":"R Freynhagen","year":"2005","unstructured":"Freynhagen R, Strojek K, Griesing T, Whalen E, Balkenohl M: Efficacy of pregabalin in neuropathic pain evaluated in a 12-week, randomised, double-blind, multicentre, placebo-controlled trial of flexible-and fixed-dose regimens. Pain. 2005, 115: 254-263. 10.1016\/j.pain.2005.02.032.","journal-title":"Pain"},{"key":"507_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1185\/030079906X80404","volume":"22","author":"R van Seventer","year":"2006","unstructured":"van Seventer R, Feister HA, Young JP, Stoker M, Versavel M, Rigaudy L: Efficacy and tolerability of twice-daily pregabalin for treating pain and related sleep interference in postherpetic neuralgia: a 13-week, randomized trial. Curr Med Res Opin. 2006, 22: 375-384. 10.1185\/030079906X80404.","journal-title":"Curr Med Res Opin"},{"key":"507_CR16","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.ejpain.2007.05.003","volume":"12","author":"T T\u00f6lle","year":"2008","unstructured":"T\u00f6lle T, Freynhagen R, Versavel M, Trostmann U, Young JP: Pregabalin for relief of neuropathic pain associated with diabetic neuropathy: a randomized, double-blind study. Eur J Pain. 2008, 12: 203-213. 10.1016\/j.ejpain.2007.05.003.","journal-title":"Eur J Pain"},{"key":"507_CR17","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1471-2377-8-33","volume":"8","author":"JC Arezzo","year":"2008","unstructured":"Arezzo JC, Rosenstock J, LaMoreaux L, Pauer L: Efficacy and safety of pregabalin 600 mg\/d for treating painful diabetic peripheral neuropathy: a double-blind placebo-controlled trial. BMC Neurol. 2008, 8: 33-10.1186\/1471-2377-8-33.","journal-title":"BMC Neurol"},{"key":"507_CR18","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/sim.1023","volume":"21","author":"JA Berlin","year":"2002","unstructured":"Berlin JA, Santanna J, Schmid CH, Szczech LA, Feldman HI: Individual patient-versus group-level data meta-regressions for the investigation of treatment effect modifiers: ecological bias rears its ugly head. Stat Med. 2002, 21: 371-387. 10.1002\/sim.1023.","journal-title":"Stat Med"},{"key":"507_CR19","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1002\/sim.1752","volume":"23","author":"JP Higgins","year":"2004","unstructured":"Higgins JP, Thompson SG: Controlling the risk of spurious findings from meta-regression. Stat Med. 2004, 23: 1663-1682. 10.1002\/sim.1752.","journal-title":"Stat Med"},{"key":"507_CR20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0895-4356(01)00414-0","volume":"55","author":"PC Lambert","year":"2002","unstructured":"Lambert PC, Sutton AJ, Abrams KR, Jones DR: A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis. J Clin Epidemiol. 2002, 55: 86-94. 10.1016\/S0895-4356(01)00414-0.","journal-title":"J Clin Epidemiol"},{"key":"507_CR21","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1017\/CBO9780511666971.011","volume":"3","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Thakur R, Griesing T, Sharma U, Young JP: Randomized clinical trials of pregabalin for neuropathic pain: methods, results, and implications. Prog Neurother Neuropsychopharmacol. 2008, 3: 167-187. full_text.","journal-title":"Prog Neurother Neuropsychopharmacol"},{"key":"507_CR22","unstructured":"European Medicines Agency Scientific Discussion-Lyrica. [\n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/EPAR_-_Scientific_Discussion\/human\/000546\/WC500046600.pdf\n                    \n                  ]"},{"key":"507_CR23","unstructured":"A placebo-controlled trial of pregabalin and amitriptyline for treatment of painful diabetic peripheral neuropathy. [\n                    http:\/\/www.clinicalstudyresults.org\/documents\/company-study_1952_0.pdf\n                    \n                  ]"},{"key":"507_CR24","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jpain.2007.09.005","volume":"9","author":"RH Dworkin","year":"2008","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, Beaton D, Cleeland CS, Farrar JT, Haythornthwaite JA, Jensen MP, Kerns RD, Ader DN, et al: Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008, 9: 105-121. 10.1016\/j.jpain.2007.09.005.","journal-title":"J Pain"},{"key":"507_CR25","volume-title":"Pain","author":"RA Moore","year":"2010","unstructured":"Moore RA, Eccleston C, Derry S, Wiffen P, Bell RF, Straube S, McQuay H: \"Evidence\" in chronic pain-establishing best practice in the reporting of systematic reviews. Pain. 2010"},{"key":"507_CR26","first-page":"CD007076","volume-title":"Cochrane Database Syst Rev","author":"RA Moore","year":"2009","unstructured":"Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ: Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev. 2009, CD007076-"},{"key":"507_CR27","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ejpain.2005.01.014","volume":"10","author":"AM McDermott","year":"2006","unstructured":"McDermott AM, Toelle TR, Rowbotham DJ, Schaefer CP, Dukes EM: The burden of neuropathic pain: results from a cross-sectional survey. Eur J Pain. 2006, 10: 127-135. 10.1016\/j.ejpain.2005.01.014.","journal-title":"Eur J Pain"},{"key":"507_CR28","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1111\/j.1533-2500.2008.00226.x","volume":"9","author":"A Berger","year":"2009","unstructured":"Berger A, Sadosky A, Dukes E, Edelsberg J, Oster G: Use of pregabalin in patients with painful neuropathic disorders under the care of general practitioners in the U.K. Pain Pract. 2009, 9: 18-34. 10.1111\/j.1533-2500.2008.00226.x.","journal-title":"Pain Pract"},{"key":"507_CR29","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1111\/j.1468-2982.2008.01788.x","volume":"29","author":"TW Ho","year":"2009","unstructured":"Ho TW, Fan X, Rodgers A, Lines CR, Winner P, Shapiro RE: Age effects on placebo response rates in clinical trials of acute agents for migraine: pooled analysis of rizatriptan trials in adults. Cephalalgia. 2009, 29: 711-718. 10.1111\/j.1468-2982.2008.01788.x.","journal-title":"Cephalalgia"},{"key":"507_CR30","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1146\/annurev.pharmtox.48.113006.094711","volume":"48","author":"F Benedetti","year":"2008","unstructured":"Benedetti F: Mechanisms of placebo and placebo-related effects across diseases and treatments. Annu Rev Pharmacol Toxicol. 2008, 48: 33-60. 10.1146\/annurev.pharmtox.48.113006.094711.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"507_CR31","doi-asserted-by":"publisher","first-page":"(10 Suppl):S22","DOI":"10.1016\/j.amjmed.2008.11.030","volume":"122","author":"AB O'Connor","year":"2009","unstructured":"O'Connor AB, Dworkin RH: Treatment of neuropathic pain: an overview of recent guidelines. Am J Med. 2009, 122: (10 Suppl):S22-S32. 10.1016\/j.amjmed.2009.04.007.","journal-title":"Am J Med"},{"key":"507_CR32","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1111\/j.1526-4637.2009.00699.x","volume":"10","author":"American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons","year":"2009","unstructured":"American Geriatrics Society Panel on the Pharmacological Management of Persistent Pain in Older Persons: Pharmacological management of persistent pain in older persons. Pain Med. 2009, 10: 1062-1083. 10.1111\/j.1526-4637.2009.00699.x.","journal-title":"Pain Med"},{"key":"507_CR33","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1097\/AJP.0b013e31802f67dd","volume":"23","author":"A Berger","year":"2007","unstructured":"Berger A, Dukes E, Edelsberg J, Stacey B, Oster G: Use of tricyclic antidepressants in older patients with diabetic peripheral neuropathy. Clin J Pain. 2007, 23: 251-258. 10.1097\/AJP.0b013e31802f67dd.","journal-title":"Clin J Pain"},{"issue":"2 Suppl","key":"507_CR34","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1016\/j.jpainsymman.2009.05.003","volume":"38","author":"BE McGeeney","year":"2009","unstructured":"McGeeney BE: Pharmacological management of neuropathic pain in older adults: an update on peripherally and centrally acting agents. J Pain Symptom Manage. 2009, 38 (2 Suppl): S15-S27. 10.1016\/j.jpainsymman.2009.05.003.","journal-title":"J Pain Symptom Manage"},{"key":"507_CR35","doi-asserted-by":"publisher","first-page":"1989","DOI":"10.1111\/j.1742-1241.2007.01589.x","volume":"61","author":"R Freynhagen","year":"2007","unstructured":"Freynhagen R, Grond S, Sch\u00fcpfer G, Hagebeuker A, Schmelz M, Ziegler D, Von Giesen HJ, Junker U, Wagner KJ, Konrad C: Efficacy and safety of pregabalin in treatment refractory patients with various neuropathic pain entities in clinical routine. Int J Clin Pract. 2007, 61: 1989-1996. 10.1111\/j.1742-1241.2007.01589.x.","journal-title":"Int J Clin Pract"},{"key":"507_CR36","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1016\/j.clinthera.2007.08.019","volume":"29","author":"M Gore","year":"2007","unstructured":"Gore M, Sadosky A, Tai KS, Stacey B: A retrospective evaluation of the use of gabapentin and pregabalin in patients with postherpetic neuralgia in usual-care settings. Clin Ther. 2007, 29: 1655-1670. 10.1016\/j.clinthera.2007.08.019.","journal-title":"Clin Ther"},{"key":"507_CR37","first-page":"S144","volume":"16","author":"M Gore","year":"2010","unstructured":"Gore M, Sadosky A, Zlateva G, Clauw D: Initial use of pregabalin, patterns of pain-related pharmacotherapy, and healthcare resource use among older patients with fibromyalgia. Am J Manag Care. 2010, 16: S144-153.","journal-title":"Am J Manag Care"}],"container-title":["BMC Family Practice"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2296-11-85\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-11-85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-11-85","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2296-11-85.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,1,23]],"date-time":"2019-01-23T10:19:18Z","timestamp":1548238758000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcfampract.biomedcentral.com\/articles\/10.1186\/1471-2296-11-85"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,11,5]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,12]]}},"alternative-id":["507"],"URL":"https:\/\/doi.org\/10.1186\/1471-2296-11-85","relation":{},"ISSN":["1471-2296"],"issn-type":[{"value":"1471-2296","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,11,5]]},"article-number":"85"}}